XENON XE-133 - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for xenon xe-133 and what is the scope of patent protection?
Xenon xe-133
is the generic ingredient in three branded drugs marketed by Curium, Ge Healthcare, Gen Electric, Lantheus Medcl, and Mallinckrodt, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for xenon xe-133. Two suppliers are listed for this compound.
Summary for XENON XE-133
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 7 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 618 |
What excipients (inactive ingredients) are in XENON XE-133? | XENON XE-133 excipients list |
DailyMed Link: | XENON XE-133 at DailyMed |
Pharmacology for XENON XE-133
Drug Class | Inhalation Diagnostic Agent |
Mechanism of Action | Radiopharmaceutical Activity |
Anatomical Therapeutic Chemical (ATC) Classes for XENON XE-133
US Patents and Regulatory Information for XENON XE-133
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gen Electric | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017550-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Mallinckrodt | XENEISOL | xenon xe-133 | SOLUTION;INHALATION, INJECTION | 017262-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Curium | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 018327-002 | Mar 9, 1982 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Ge Healthcare | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017256-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
XENON XE-133 Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.